Kevin J. Yeaman, President and CEO at Dolby Laboratories, Inc. (DLB), sold 115,776 shares at $80.19 ($9.3M) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Scheduled sale ($9.3M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.53 | 49,104 | $4.0M | 42.4% |
| 2 | $80.53 | 49,104 | $4.0M | 42.4% |
| 3 | $81.18 | 896 | $73K | 0.8% |
| 4 | $81.18 | 896 | $73K | 0.8% |
| 5 | $80.19 | 7,888 | $633K | 6.8% |
| 6 | $80.19 | 7,888 |
| $633K |
| 6.8% |
| Total | $80.49 avg | 115,776 | $9.3M | 100% |
| Filing → |
| DLB | SELL | 2025-11-26 | $4.9M | — | Filing → |
| DLB | SELL | 2025-10-16 | $3.4M | — | Filing → |
| DLB | SELL | 2025-09-18 | $1.8M | — | Filing → |